Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-10-30
|
pubmed:abstractText |
1-[(2-Fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole (flutrimazole, UR-4056, CAS 119006-77-8) is a new topical imidazole antifungal agent which displays potent broad-spectrum in vitro activity against dermatophytes, filamentous fungi and yeasts, saprophytic and pathogenic to animals and humans (MIC = 0.025-5.0 micrograms/ml). In most of these studies the activity of flutrimazole was comparable to that of clotrimazole and markedly higher than that of bifonazole (MIC differences of greater than or equal to 1 order of magnitude). Tested against Scopulariopsis brevicaulis (8 strains), both flutrimazole and clotrimazole exhibited fungistatic and fungicidal activity, and clotrimazole appeared something less active (MIC = 0.3-2.5 micrograms/ml) than flutrimazole (MIC = 0.15-0.6 micrograms/ml). In animal experiments, topical application of 1% and 2% flutrimazole, as a cream or solution, was highly effective in models of rat vaginal candidiasis and guinea-pig trichophytosis, giving a rate of cured or cured plus markedly improved animals higher than 80%. Flutrimazole shares the mode of action of other imidazole or triazole-containing antifungals, i.e. inhibition of fungal lanosterol 14 alpha-demethylase, as it strongly inhibits ergosterol biosynthesis in a cell-free homogenate of Candida albicans, with an IC50 value of 0.071 mumol/l.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Clotrimazole,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/bifonazole,
http://linkedlifedata.com/resource/pubmed/chemical/flutrimazole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0004-4172
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
836-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1418042-Animals,
pubmed-meshheading:1418042-Antifungal Agents,
pubmed-meshheading:1418042-Candidiasis, Vulvovaginal,
pubmed-meshheading:1418042-Clotrimazole,
pubmed-meshheading:1418042-Female,
pubmed-meshheading:1418042-Fungi,
pubmed-meshheading:1418042-Guinea Pigs,
pubmed-meshheading:1418042-Imidazoles,
pubmed-meshheading:1418042-Male,
pubmed-meshheading:1418042-Microbial Sensitivity Tests,
pubmed-meshheading:1418042-Mycoses,
pubmed-meshheading:1418042-Rats,
pubmed-meshheading:1418042-Rats, Wistar,
pubmed-meshheading:1418042-Tinea
|
pubmed:year |
1992
|
pubmed:articleTitle |
In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
|
pubmed:affiliation |
Research Center, J. Uriach & Cía, S.A., Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|